Revenue segments as reported by the company.

Premiums

Services

Investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Benefits

Operating costs

Depreciation and amortization

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Humana

Humana Inc. engages in the provision of health insurance services. The firm operates through the following segments: Retail, Group and Specialty and Healthcare Services. The Retail segment consists of products sold on a retail basis to individuals including medical and supplemental plans such as Medicare, and State-based contracts. The Group and Specialty segment contains employer group fully-insured commercial medical products and specialty health insurance benefits marketed to individuals and groups, including dental, vision, military services and other supplemental health & voluntary insurance. The Healthcare Services segment offers services such as pharmacy solutions, provider services, clinical care, predictive modeling and informatics to other Humana businesses, as well as external health plan members, and other employers. The company was founded by David A. Jones, Sr., and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Humana exceeds earnings expectations, focuses on value-based care growth

Humana's strong financial performance and growth in value-based care position the company well for future success. Addressing audit error rates, uncertainties around RADV, and managing costs are key challenges. Opportunities in recruiting, revenue growth, and strategic partnerships offer avenues for further growth.

Humana exceeds Q1 expectations, eyes industry growth amidst challenges

Humana's strong Q1 performance and strategic decisions position it well for growth
Challenges like rate disruptions and Medicaid redeterminations require close monitoring
Opportunities in industry growth, member engagement, and benefit enhancements ahead
Commitment to long-term goals and high-quality service evident in company's outlook

Humana meets Q2 expectations, eyes growth in MA platform

Humana's Q2 performance met expectations with a focus on MA platform growth and disciplined investments.
Challenges include higher utilization in Medicare Advantage and broad-based medical cost trends.
Strategic benefits adjustments and competitive positioning present opportunities for growth and margin expansion.
Expectations for 2024 include maintaining market share, offsetting costs, and achieving strong membership growth.

Humana surpasses Q3 earnings expectations, eyes $37 EPS target

Humana's Q3 performance exceeded expectations, with strong membership growth and strategic initiatives driving future profitability.
While facing challenges in benefit ratios and regulatory changes, Humana remains focused on achieving long-term financial targets.
The company's commitment to operational excellence, membership growth, and pricing actions positions it for sustained success.
Strategic partnerships and risk management efforts showcase Humana's resilience and adaptability in a dynamic healthcare landscape.

Humana faces challenges from rising costs but eyes long-term growth

Humana's Q4 2023 earnings call highlighted challenges from increased medical costs and utilization trends impacting financial performance and outlook.
Despite disappointments in short-term results, the company remains confident in the long-term attractiveness of the Medicare Advantage sector.
Strategic efforts to restore margins, address utilization drivers, and engage with providers reflect a proactive approach to managing industry dynamics.
Balancing profitability with membership growth through benefit adjustments and pricing actions is crucial for Humana's sustainable financial performance.

Humana reports solid Q1 performance, eyes margin recovery in 2025

Humana's Q1 2024 earnings call highlighted a strong start to the year, challenges in the industry for 2025, and a focus on margin recovery and growth opportunities. The company remains confident in its outlook, emphasizing pricing discipline and maintaining a strong value proposition in the market.

Humana surpasses Q2 expectations, addresses cost pressures for growth

Humana's Q2 2024 performance exceeded expectations, driven by strong Medicare business and growth in Medicaid and primary care segments.
Challenges such as medical cost pressures were addressed through mitigation measures, while opportunities lie in strategic initiatives and long-term planning.
The company's focus on value, disciplined cost management, and operational efficiency position it well for sustained growth and value creation.

Humana surpasses Q3 expectations, eyes growth through efficiency and investments

Humana's Q3 performance exceeded expectations, with a focus on balancing earnings and investments. The company is strategically positioned to drive growth through membership expansion and operational efficiency. Challenges include managing costs and understanding market dynamics, with opportunities in improving Stars ratings and expanding senior care services.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Humana Inc. engages in the provision of health insurance services. It operates through the Insurance and CenterWell segments. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as contract with CMS to administer the Limited Income Newly Eligible Transition, or LI-NET, prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits, which refer to as state-based contracts. The CenterWell segment represents payor-agnostic healthcare services offerings, including pharmacy dispensing services, provider services, and home services. The company was founded by David A. Jones, Sr., and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY.

Cigna

Cigna Group (NYSE: CI) is trending down at writing following a report that it may soon merge with peer Humana Inc (NYSE: HUM). Cigna and Humana are discussing a potential merger Anonymous sources told the Wall Street Journal today that two of the largest U.S. health insurers are “in talks” over a stock-and-cash deal.

Cigna may soon merge with Humana: report

The Wall Street Journal says the two healthcare providers are talking about a stock-and-cash deal that could be finalized by the end of the year.

Cigna and Humana Are in Merger Talks, Report Says

Health insurers Cigna and Humana are in talks for a merger, the Wall Street Journal reported on Wednesday, citing people familiar with the matter.

Health insurers Humana, Cigna in talks to merge - WSJ

Shares of Cigna fell on Wednesday after a report that the company is in talks with Humana about a merger between the two health care giants.

Cigna shares slide after report it could merge with Humana

Managed-care providers Cigna Group CI, -2.76% and Humana Inc. HUM, +0.17% are in talks to combine in a cash-and-stock deal that could be finalized before year-end, the Wall Street Journal reported Wednesday, citing people familiar with the matter. Cigna's market value stands at about $83 billion, while Humana's is about $62 billion, suggesting it would be mega deal.

Cigna and Humana in talks on combining in what would be a mega deal: WSJ

A cash-and-stock deal between the health-insurance giants could be struck by year-end.

Cigna, Humana in Talks for Blockbuster Merger

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Why Humana (HUM) is a Top Growth Stock for the Long-Term

Centene

Molina Healthcare

UnitedHealth Group

Rising premiums, contract wins, a telehealth services suite and the M&A strategy are expected to drive the performances of the Zacks Medical-HMO industry players. UNH, CI, HUM, CNC and MOH are poised to benefit from encouraging industry prospects.

5 HMO Stocks Set to Gain From Growing Membership, Tech Advancements

American Express

Bank of America

Is investing in the stock market really as risky as gambling in a Vegas casino? Well, it depends.

3 Blue-Chip Stocks You'll Regret Not Buying Soon: November 2023

LOUISVILLE, Ky.--(BUSINESS WIRE)--Value-based care is smarter healthcare that lowers costs and keeps Medicare Advantage members healthier, according to the tenth annual Value-Based Care Report released today from Humana Inc. (NYSE: HUM). The 2023 report shows that Medicare Advantage (MA) patients receiving care under value-based arrangements spent more time with their primary care physician and were more likely to receive preventive care, with fewer hospitalizations. Meanwhile, physicians worki.

Value-Based Care Benefits Patients and Physicians, New Report Shows

LOUISVILLE, Ky.--(BUSINESS WIRE)--The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE: HUM) for the past 41 years, today announced a series of grants advancing its regional health equity mission by supporting seniors and school-aged children in living connected, healthy lives. The 23 grants spanning four geographies – Kentucky, Florida, Louisiana and Texas – and four Health Equity Innovation Fund projects will help beneficiaries create healthy emotional connections and shape a hea.

Humana Foundation Invests in Innovative Mental Health and Nutrition Programming for Seniors and School-Aged Children

Humana's (HUM) CenterWell brand will open four senior-focused primary care centers across Indianapolis in order to address the unique needs of the area's senior population.

Humana's (HUM) CenterWell Unit Plans Expansion in Indiana

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (the “company”) (NYSE: HUM) announced today the completion of its public offering of $1.35 billion in aggregate principal amount of senior notes. These senior notes are comprised of $500 million of the company's 5.750 percent senior notes, due 2028, at 99.830 percent of the principal amount, and $850 million of the company's 5.950 percent senior notes, due 2034, at 98.525 percent of the principal amount (collectively, the “Senior Notes Offerings”).

Humana Completes Aggregate $1.35 Billion Debt Offering

TAMPA, Fla.--(BUSINESS WIRE)--Humana Healthy Horizons partners with the Alzheimer's Association to educate and support Floridians.

Humana Healthy Horizons partners with the Alzheimer's Association to educate and support Floridians

CVS Health

Buy-and-hold investing may seem like a boring activity, but it is the path to sustained wealth building. Building positions over time that leverage growth, capital returns, and capital return growth results in accelerating returns and market-beating performance.

3 healthy dividend stocks for buy and hold investors

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Announces Sponsorships of Leading U.S. Pickleball Organizations to Inspire and Promote Active and Healthy Lifestyles, With a Focus on Seniors.

Humana Announces Four New Sponsorships of Leading U.S. Pickleball Organizations to Inspire and Promote Active and Healthy Lifestyles for All Ages, With a Special Focus on Seniors

OLDWICK, N.J.--(BUSINESS WIRE)-- #insurance--AM Best has assigned a Long-Term Issue Credit Rating (Long-Term IR) of “bbb” (Good) to the recently announced $500 million, 5.75 % senior unsecured notes, due 2028, and the $850 million, 5.95% senior unsecured notes, due 2034, issued by Humana Inc. (Humana) (headquartered in Louisville, KY) [NYSE: HUM]. The outlook assigned to these Credit Ratings (ratings) is stable. Humana's Long-Term Issuer Credit Rating of “bbb” (Good), its Long-Term IRs and the ratings of it.

AM Best Assigns Issue Credit Ratings to Humana Inc.'s Senior Unsecured Notes

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (the “company”) (NYSE: HUM) announced today that it has priced a public offering of $1.35 billion in aggregate principal amount of senior notes. These senior notes are comprised of $500 million of the company's 5.750 percent senior notes, due 2028, at 99.830 percent of the principal amount, and $850 million of the company's 5.950 percent senior notes, due 2034, at 98.525 percent of the principal amount (collectively, the “Senior Notes Offerings”). T.

Humana Prices $1.35 Billion Debt Offering

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) announced today that Susan M. Diamond, Chief Financial Officer, will make a presentation to investors at the Stephens Annual Investment Conference on Wednesday, November 15, 2023, at 8:00 a.m. Central time. A live audio webcast of the presentation will be available via Humana's Investor Relations page at humana.com. The company suggests webcast participants sign on approximately 15 minutes in advance of the presentation to allow time to.

Humana Inc. to Present at the Stephens Annual Investment Conference

Humana (HUM) continues to project 2023 adjusted EPS at a minimum of $28.25, which suggests growth from the 2022 figure of $25.88.

Humana (HUM) Q3 Earnings Beat on Strong Individual MA Unit

Humana Inc. (NYSE:HUM ) Q3 2023 Earnings Conference Call November 1, 2023 9:00 AM ET Company Participants Lisa Stoner - Vice President of Investor Relations Bruce Broussard - President & Chief Executive Officer Susan Diamond - Chief Financial Officer Conference Call Participants Kevin Fischbeck - Bank of America Stephen Baxter - Wells Fargo Scott Fidel - Stephens A.J. Rice - Credit Suisse Justin Lake - Wolfe Research Joshua Raskin - Nephron Research Gary Taylor - Cowen George Hill - Deutsche Bank Sarah James - Cantor Fitzgerald Lance Wilkes - Bernstein Nathan Rich - Goldman Sachs Benjamin Mayo - Leerink Partners Operator Good day and thank you for standing by.

Humana Inc. (HUM) Q3 2023 Earnings Call Transcript

The headline numbers for Humana (HUM) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Humana (HUM) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Humana Inc.'s stock HUM rose 0.3% in premarket trading on Wednesday after the health insurance company's third-quarter net income and revenue beat analyst estimates. Humana said its third-quarter profit fell to $1.1 billion, or $6.71 a share, from $1.3 billion, or $9.39 a share, in the year-ago quarter.

Humana Q3 net income, revenue beats analyst estimate

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) today reported consolidated pretax results and diluted earnings per share (EPS) for the quarter ended September 30, 2023 (3Q23) versus the quarter ended September 30, 2022 (3Q22) and for the nine months ended September 30, 2023 (YTD 2023) versus the nine months ended September 30, 2022 (YTD 2022) as noted in the tables below. Consolidated income before income taxes and equity in net earnings (pretax results) In millions 3Q23 (a) 3Q22 (a).

Humana Reports Third Quarter 2023 Financial Results; Affirms Full Year 2023 Adjusted EPS Guidance

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana repeats as U.S. News & World Report's Best Overall Medicare Advantage Plan Company for the second year in a row.

News for Humana Stock (HUM)